Udac, Baby Boy .

HRN: 21-72-94  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/19/2022
08/25/2022
IVT
30
OD
PoTentially Septic Newborn
Waiting Final Action 
08/19/2022
AMPICILLIN 250MG (VIAL)
08/19/2022
08/25/2022
IVT
125mg
Q12
Potentially Septic Newborn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: